Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 329

Results For "EIR"

3316 News Found

Govt. allocates 16.5 lakh vials of Remdesivir between May 3-9
News | May 06, 2021

Govt. allocates 16.5 lakh vials of Remdesivir between May 3-9

Seven manufacturers of Remdesivir have increased production capacity to 1.03 crore vials per month up from 38 lakh vials per month a month ago


Glenmark launches Ryaltris-AZ at affordable price
News | May 04, 2021

Glenmark launches Ryaltris-AZ at affordable price

First company in the world to launch Ryaltris-AZ, as a novel fixed dose combination of Mometasone furoate 50 mcg + Azelastine 140 mcg


Lonza will invest CHF 200 mn to construct manufacturing complex
News | April 26, 2021

Lonza will invest CHF 200 mn to construct manufacturing complex

New manufacturing complex will occupy an overall footprint of approximately 2,000 square meter with six levels of manufacturing space


Serum not contracted for complete production of COVID vaccine to centre
News | April 23, 2021

Serum not contracted for complete production of COVID vaccine to centre

These media reports are based on incorrect facts and are without any basis.


Pharma and medical device to play a pivotal role: Gowda
News | April 21, 2021

Pharma and medical device to play a pivotal role: Gowda

The Department of Pharmaceuticals launched the PLI scheme for promoting domestic manufacturing of bulk drugs, with a financial outlay of Rs. 6,940 crore across 53 APIs over 6 years


Indian pharma industry registers 18% exports growth: Narendra Modi
Policy | April 20, 2021

Indian pharma industry registers 18% exports growth: Narendra Modi

Essential medicines were made available to more than 150 countries around the world during the pandemic


Zydus seeks DCGI approval for the use of Pegylated Interferon alpha-2b in treating COVID-19
News | April 05, 2021

Zydus seeks DCGI approval for the use of Pegylated Interferon alpha-2b in treating COVID-19

PegIFN in COVID19 has several add-on advantages compared to other anti-viral agents


Tatva Chintan Pharma Chem plans for IPO files DRHP with SEBI
News | April 05, 2021

Tatva Chintan Pharma Chem plans for IPO files DRHP with SEBI

TCPCL is the largest and only commercial manufacturer of SDAs for zeolites in India


Lonza completes divestment of two sites to NextPharma
News | April 02, 2021

Lonza completes divestment of two sites to NextPharma

Strategic divestment of Ploermel and Edinburgh sites will enable NextPharma to benefit from operational synergies and optimize existing expertise and technologies